ARTICLE | Clinical News
Embeda regulatory update
November 2, 2009 8:00 AM UTC
FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) issued a warning letter to King citing two video news releases promoting Embeda extended-release morphine/naltrexone. The agen...